Publication | Closed Access

An anti-rheumatic agent T-614 inhibits NF-κB activation in LPS- and TNF-α-stimulated THP-1 cells without interfering with IκBα degradation

InflammationRheumatologyAnti-inflammatoryIκbα DegradationAutoimmune DiseaseRheumatic DiseasesImmunologyImmune RegulationChronic InflammationInflammatory Rheumatic DiseaseInnate ImmunityNf-κb ActivationMedicineCell BiologyAnti-rheumatic Agent T-614